on 10 Dec 2024
Last Applicant/ Owned by
310 East 67th Street
New York
NY
10065
Serial Number
97202507 filed on 04th Jan 2022
Registration Number
7599939 registered on 10th Dec 2024
Correspondent Address
CYNTHIA JOHNSON WALDEN
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Biomedical research and development services in the field of transfusion medicine, regenerative medicine and cellular therapy related research and clinical programs from discovery through development and to the clinic Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; collection and preservation of human blood, red blood Read More
Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; collection and preservation of human blood, red blood cells, plasma and bone
13th Aug 2024
13th Aug 2024
Biomedical research and development services in the field of transfusion medicine, regenerative medicine and cellular therapy related research and clinical programs from discovery through development and to the clinic
13th Aug 2024
13th Aug 2024
Venture capital fund management; venture capital advisory services; venture capital services, namely, providing financing to emerging and start-up companies; investment management
13th Aug 2024
13th Aug 2024
No 97202507
No Service Mark
No 584340087001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
10th Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
10th Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
06th Dec 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
06th Dec 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
06th Dec 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
15th Nov 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
15th Nov 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
14th Nov 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
14th Nov 2024 | STATEMENT OF USE PROCESSING COMPLETE |
13th Sep 2024 | TEAS STATEMENT OF USE RECEIVED |